Cryomass (CRYM) 10-Q 7 Aug 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2020	Aug. 07, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Redwood Green Corp.
Entity Central Index Key	0001533030
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		92,652,257
Entity File Number	000-56155
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents (Note 2)	$ 611,863	$ 3,473,770
Accounts receivable, net (Note 2)	720,000
Prepaid expenses	176,840	100,555
Inventory, net (Note 2)		340,000
Assets held for sale, current	11,900,048	11,845,681
Total current assets	13,408,751	15,760,006
Total assets	13,408,751	15,760,006
Current liabilities:
Accounts payable and accrued expenses (Note 2)	1,603,403	754,850
Taxes payable	771
Liabilities held for sale, current	1,710,089	1,913,433
Total current liabilities	3,314,263	2,668,283
Deferred tax liability	5,117	4,691
Total liabilities	3,319,380	2,672,974
Commitments and contingencies (Note 15)
Shareholders' equity:
Preferred stock, $0.001 par value, 100,000 shares authorized, no shares issued and outstanding respectively
Common stock, $0.001 par value, 500,000,000 shares authorized, 92,942,257 and 106,216,708 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively	107,992	106,216
Additional paid-in capital	18,264,983	16,894,103
Accumulated deficit	(8,283,604)	(3,913,287)
Total shareholders' equity	10,089,371	13,087,032
Total liabilities and shareholders' equity	$ 13,408,751	$ 15,760,006

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	92,942,257	106,216,708
Common stock, shares outstanding	92,942,257	106,216,708

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Net sales	$ 769,555		$ 781,455
Cost of goods sold, inclusive of provision for inventory loss of $0 and $400,787 for the three and six months, respectively, ended June 30, 2020	310,695		744,279
Gross profit	458,860		37,176
Operating expenses:
Personnel costs	687,573		1,416,685
Sales and marketing	237		14,854
General and administrative	219,054	222,238	1,799,762	269,860
Legal and professional fees	243,561		927,315
Total operating expenses	1,150,425	222,238	4,158,616	269,860
Loss from operations	(691,565)	(222,238)	(4,121,440)	(269,860)
Other income (expenses):
Loss on foreign exchange	(16,011)	16	(16,011)	(430)
Total other expenses	(16,011)	16	(16,011)	(430)
Net loss from continuing operations, before taxes	(707,576)	(222,222)	(4,137,451)	(270,290)
Income taxes	5,117		5,117
Net loss from continuing operations	(712,693)	(222,222)	(4,142,568)	(270,290)
Net loss from discontinued operations, net of tax	(60,315)	991	(227,749)	(22,279)
Net loss	(773,008)	(221,231)	(4,370,317)	(292,569)
Comprehensive loss from discontinued operations		(5,824)		(5,370)
Comprehensive loss	$ (773,008)	$ (227,055)	$ (4,370,317)	$ (297,939)
Net loss per common share:
Loss from continuing operations - basic and diluted	$ (0.01)	$ 0	$ (0.04)	$ 0
Loss from discontinued operations - basic and diluted	0	0	0	0
Loss per common share - basic and diluted	$ (0.01)	$ 0	$ (0.04)	$ 0
Weighted average common shares outstanding-basic and diluted	105,243,905	76,949,642	105,957,797	76,676,347

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Income Statement [Abstract]
Provision for inventory loss	$ 0	$ 400,787

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Common Stock to be Issued	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Balance at Dec. 31, 2018	$ 76,400	$ 1,425,885		$ (840,656)	$ (15,097)	$ 646,532
Balance, shares at Dec. 31, 2018	76,400,016
Net loss				(71,338)	454	(70,884)
Balance at Mar. 31, 2019	$ 76,400	1,425,885		(911,994)	(14,643)	575,648
Balance, shares at Mar. 31, 2019	76,400,016
Balance at Dec. 31, 2018	$ 76,400	1,425,885		(840,656)	(15,097)	646,532
Balance, shares at Dec. 31, 2018	76,400,016
Net loss						(292,569)
Balance at Jun. 30, 2019	$ 81,837	4,091,698	438,400	(1,133,225)	(20,467)	3,458,243
Balance, shares at Jun. 30, 2019	81,837,016
Balance at Mar. 31, 2019	$ 76,400	1,425,885		(911,994)	(14,643)	575,648
Balance, shares at Mar. 31, 2019	76,400,016
Common stock issued pursuant to private placement, net of issuance costs	$ 5,437	2,665,813				2,671,250
Common stock issued pursuant to private placement, net of issuance costs, shares	5,437,000
Common stock to be issued pursuant to private placement			438,400			438,400
Net loss				(221,231)	(5,824)	(221,231)
Balance at Jun. 30, 2019	$ 81,837	4,091,698	438,400	(1,133,225)	(20,467)	3,458,243
Balance, shares at Jun. 30, 2019	81,837,016
Balance at Dec. 31, 2019	$ 106,216	16,894,103		(3,913,287)		13,087,032
Balance, shares at Dec. 31, 2019	106,216,708
Issuance of common stock pursuant to separation agreement	$ 1,176	763,049				764,225
Issuance of common stock pursuant to separation agreement, shares	1,175,549
Issuance of common stock pursuant to accelerated vesting of restricted stock units	$ 600	389,460				390,060
Issuance of common stock pursuant to accelerated vesting of restricted stock units, shares	600,000
Stock-based compensation		159,529				159,529
Net loss				(3,597,309)		(3,597,309)
Balance at Mar. 31, 2020	$ 107,992	18,206,141		(7,510,596)		10,803,537
Balance, shares at Mar. 31, 2020	107,992,257
Balance at Dec. 31, 2019	$ 106,216	16,894,103		(3,913,287)		13,087,032
Balance, shares at Dec. 31, 2019	106,216,708
Net loss						(4,370,317)
Balance at Jun. 30, 2020	$ 107,992	18,264,983		(8,283,604)		10,089,371
Balance, shares at Jun. 30, 2020	92,942,257
Balance at Mar. 31, 2020	$ 107,992	18,206,141		(7,510,596)		10,803,537
Balance, shares at Mar. 31, 2020	107,992,257
Share cancellations
Share cancellations, shares	(15,050,000)
Stock-based compensation		58,842
Net loss				(773,008)		(773,008)
Balance at Jun. 30, 2020	$ 107,992	$ 18,264,983		$ (8,283,604)		$ 10,089,371
Balance, shares at Jun. 30, 2020	92,942,257

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,142,568)	$ (292,569)
Adjustments to reconcile net loss to net cash used in operating activities from continuing operations:
Provision for inventory loss	400,787
Stock-based compensation expense	1,372,656
Deferred income tax expense	426
Change in operating assets and liabilities:
Accounts receivable	(720,000)
Prepaid expenses	(76,285)	(4,863)
Inventory, net	(60,787)
Accounts payable and accrued expenses	848,553	118,261
Assets held for sale	7,134
Taxes payable	771
Net cash used in operating activities from continuing operations	(2,369,313)	(179,171)
Net cash used in operating activities from discontinued operations	(41,332)	(13,159)
Net cash used in operating activities	(2,410,645)	(192,330)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities from continuing operations
Net cash used in investing activities from discontinued operations	(451,262)
Net cash used in investing activities	(451,262)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds of notes payable, related parties		126
Proceeds from sale of common stock issued		2,718,500
Equity issuance costs		(47,250)
Proceeds from common stock subscribed and to be issued		438,400
Net cash provided by financing activities from continuing operations		3,109,776
Net cash provided by financing activities from discontinued operations
Net cash provided by financing activities		3,109,776
Net decrease in cash from continuing operations	(2,369,313)	2,930,605
Net decrease in cash from discontinued operations	(492,594)	(13,159)
Effect of exchange rate changes on cash		(3,914)
Cash at beginning of period	3,473,770	207,313
Cash at end of period	611,863	3,120,845
Supplemental disclosure of cash flow information:
Cash paid for interest	6,855
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued pursuant to separation agreement	764,225
Common stock issued pursuant to vesting of restricted stock units	$ 390,060

Nature of the Business

Nature of the Business	6 Months Ended
	Jun. 30, 2020
Nature of Business and Basis of Presentation [Abstract]
Nature of the Business	1. Nature of the Business Redwood Green Corp ("Redwood Green" or the "Company") began as Auto Tool Technologies Inc., which was incorporated under the laws of the State of Nevada on May 10, 2011. The Company's name was changed to AFC Building Technologies Inc. effective January 10, 2014. Effective April 26, 2018, the Company changed its name to First Colombia Development Corp. Subsequently, effective October 14, 2019, the Company changed its name to Redwood Green Corp. On May 10, 2018, the Company acquired all the issued and outstanding share capital of First Colombia Devco S.A.S. ("Devco") a Colombian company, and began to establish various business ventures in Colombia in the agriculture and real estate development, tourism, and infrastructure sectors before commencing to phase them out in April 2019. On July 1, 2019, the Company acquired 100% of the membership interests in General Extract, LLC ("General Extract"), a Colorado limited liability company. General Extract was founded in 2015 as an importer, distributor, broker and postprocessor of hemp and hemp derivatives. The Company acquired all of the issued and outstanding membership interests, including business plans and access to contacts. On July 15, 2019, the Company, through its wholly owned subsidiary Good Acquisition Co., entered into a Membership Interest Purchase Agreement to acquire cannabis brands and other assets of Critical Mass Industries LLC DBA Good Meds ("CMI" and/or "Good Meds"), a Colorado limited liability company ("CMI Transaction"). CMI is licensed by the Marijuana Enforcement Division of Colorado Department of Revenue to produce cannabis and cannabis products under its six licenses. These licenses allow for cultivation, manufacturing of infused products and retail distribution. At the time the Company entered into the Membership Interest Purchase Agreement, Colorado law prohibited public companies, including the Company, from owning cannabis licenses. Therefore, CMI spun off certain assets acquired by the Company. Under the terms of the Membership Interest Purchase Agreement, CMI retained the cannabis license, inventory and accounts receivable (the "Cannabis License Assets") and will continue to operate the cannabis business related to those assets. In consideration for the transfer of the acquired assets, the Company delivered 13,553,233 shares of the Company common stock, in addition to $1,999,770 in cash to CMI. An additional 1,500,000 shares of Redwood Green common stock were held and retained by the Company until the Cannabis License Assets can be purchased (see Note 2 and Note 7). Good Meds, the operating unit of CMI, is based in Denver, CO, and operates in a 60,000-square-foot cultivation and processing facility. Good Meds also owns and operates two medical cannabis dispensaries located in Lakewood, CO and Englewood, CO. The business has been in operation since 2009. The Denver facility produces cannabis for sale as dry flower and biomass input for processing into Marijuana-Infused Products ("MIP"), such as live resin, wax and shatter. Redwood Green operates two medical marijuana dispensaries and related businesses in Colorado (see Note 2). Our mission is to deliver high-quality, safely manufactured, sustainable, innovative, and accessible cannabis products which support individual well-being.

Variable Interest Entity

Variable Interest Entity	6 Months Ended
	Jun. 30, 2020
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]
Variable Interest Entity	2. Variable Interest Entity Pursuant to Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Section 810 , Consolidation Under ASC 810, a reporting entity has a controlling financial interest in a VIE, and must consolidate that VIE, if the total equity investment at risk is not sufficient to permit the legal entity to finance its activities without additional subordinated financial support provided by any parties, including equity holders. As of July 15, 2019, the Company consolidates CMI as a VIE pursuant to certain intellectual property, administrative and consulting agreements in which the Company is deemed the primary beneficiary of CMI. Accordingly, the results of CMI have been included in the accompanying condensed consolidated financial statements. Furthermore, the Company notes it does not own the Cannabis License Assets; however, pursuant to accounting principles generally accepted in the United States ("GAAP"), the Cannabis License Assets are consolidated in the accompanying consolidated financial statements along with certain liabilities and the associated revenues and expenses of CMI. See Note 8 for further information regarding CMI. Description As of June 30, As of Current assets Cash and cash equivalents $ 258,703 $ 467,460 Accounts receivable, net 36,847 113,599 Inventory, net 820,320 768,633 Total current assets 1,115,870 1,349,692 Total assets $ 1,115,870 $ 1,349,692 Current liabilities Accounts payable and accrued expenses $ 259,450 $ 337,386 Total current liabilities 259,450 337,386 Total liabilities 259,450 337,386 Net assets $ 856,420 $ 1,012,306 Description For the Three Months Ended For the Six Months Ended Net sales $ 1,746,977 $ 3,328,867 Cost of goods sold, inclusive of depreciation 1,249,875 2,628,051 Gross profit $ 497,102 $ 700,816 Operating expenses Personnel costs 97,603 182,767 Sales and marketing 276,554 474,698 General and administrative 62,604 131,710 Legal and professional fees 12,936 21,231 Amortization expense 8,967 17,934 Total operating expenses 458,664 828,340 Gain from operations $ 38,438 $ (127,524 ) Interest expense 98,753 100,225 Total other expenses 98,753 100,225 Net income $ (60,315 ) $ (227,749 )

Revision of Prior Period Financ

Revision of Prior Period Financial Statements	6 Months Ended
	Jun. 30, 2020
Revision of Prior Period Financial Statements [Abstract]
Revision of Prior Period Financial Statements	3. Revision of Prior Period Financial Statements On the consolidated balance sheet for the year ended December 31, 2019 and the quarter ended September 30, 2019, the Cannabis License Assets of CMI, a VIE in which the Company is deemed the primary beneficiary (Note 2), was presented as non-controlling interest pursuant to and in conjunction with the CMI Transaction. The Company does not own the Cannabis License Assets; however, they are included in the accompanying consolidated financial statements for GAAP reporting purposes. The Company revised its consolidated financial statements in which this line item was adjusted to correct the classification by reflecting accounts receivable, net of $113,599, inventory, net of $768,633, and accounts payable and accrued expenses of $337,386 in addition to a decrease in goodwill of $1,192,234 and an increase in additional-paid-in capital of $647,458. The impact of these adjustments on the Company's consolidated financial statements was as follows: December 31, 2019 Previously Non-controlling Revised (1) Inventory, net (2) $ 340,000 $ 768,633 $ 1,108,633 Accounts receivable, net (2) $ - $ 113,599 $ 113,599 Total current assets $ 3,933,047 $ 882,232 $ 4,815,279 Goodwill $ 5,855,748 $ (1,192,234 ) $ 4,663,514 Total assets $ 16,070,008 $ (310,002 ) $ 15,760,006 Accounts payable and accrued expenses $ 754,850 $ 337,386 $ 1,092,236 Total current liabilities $ 1,558,821 $ 337,386 $ 1,896,207 Total liabilities $ 2,335,588 $ 337,386 $ 2,672,974 Additional paid-in capital $ 16,246,645 $ 647,458 $ 16,894,103 Non-controlling interests in consolidated variable interest entity $ 1,294,846 $ (1,294,846 ) $ - Total shareholders' equity $ 13,734,420 $ (647,388 ) $ 13,087,032 Total liabilities and shareholders' equity $ 16,070,008 $ (310,002 ) $ 15,760,006 (1) There was no impact to the Company's consolidated statements of operations. (2) The Company does not own the VIE's portion of this asset. Amounts relating to the VIE are accounts receivable, net of $113,599 and inventory, net of $768,633.

Going Concern Uncertainty, Fina

Going Concern Uncertainty, Financial Conditions and Management's Plans	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern Uncertainty, Financial Conditions and Management's Plans	4. Going Concern Uncertainty, Financial Conditions and Management's Plans The Company believes that there is substantial doubt about the Company's ability to continue as a going concern. The Company believes that its available cash balance as of the date of this filing will not be sufficient to fund its anticipated level of operations for at least the next twelve months. The Company believes that, at the present time, its ability to continue operations depends on the sale of assets as well as its ability to access capital markets when necessary to accomplish the Company's strategic objectives. The Company believes that the Company will continue to incur losses for the immediate future. The Company expects to finance future cash needs from the results of operations and, depending on the results of operations, the Company will need additional equity, debt financing or assets sales until the Company can achieve profitability and positive cash flows from operating activities, if ever. There can be no assurance that the Company will be able to attract needed financing or be able to sell assets on reasonable terms, if at all. On March 11, 2020, the 2019 novel coronavirus ("COVID-19) was characterized as a "pandemic." The Company's manufacturing operations were impacted during the quarter in the United States. The impact of COVID-19 developments and uncertainty with respect to the economic effects of the pandemic has introduced significant volatility in the financial markets and is having a widespread adverse effect on the cannabis industry, including reductions in certain consumer demand and production of THC-dominant and CBD-dominant cannabis that the Company specializes in. The Company assessed certain accounting matters that require consideration of forecasted financial information, including, but not limited to, the carrying value of the Company's goodwill, intangible assets, and other long-lived assets, and valuation allowances in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2020 and through the date of this report. The Company's future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Condensed Consolidated Financial Statements in future reporting periods. Our unaudited financial statements for the six months ended June 30, 2020 have been prepared on a going concern basis and contain an additional explanatory paragraph which identifies issues that raise substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty. The continuation of our company as a going concern is dependent upon the continued financial support from its shareholders, the ability of our company to obtain necessary equity or debt financing to continue operations, the sale of assets, and ultimately the attainment of profitable operations. For the six months ended June 30, 2020, our company used $2,410,645 of cash for operating activities, incurred a net loss of $4,370,317 and has an accumulated deficit of $8,283,604 since inception. These factors raise substantial doubt regarding our company's ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should our company be unable to continue as a going concern. The (COVID-19) pandemic and responses to this crisis, including actions taken by federal, state and local governments, have had an impact on the operations of the company, including, without limitation, the following: reduced staffing due to employee suspected conditions and social distancing measures; constraints on productivity; management and staff non-essential business-related travel was constrained due to stay-at-home orders; most employees have shifted to remote work resulting in loss of productivity; consumers visiting dispensaries operated under license impacted by stay-at-home orders. Management has made reasonable alternative arrangements, including attempts to render meetings and other workflow processes more efficient despite remote work; however, these have had limited success as at-home working conditions differ and certain employees' roles are not amenable to work from home. Management continues to monitor the COVID-19 pandemic situation and federal, state and local recommendations and will provide updates as appropriate.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	5. Summary of Significant Accounting Policies Principles of Consolidation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information and with the Securities and Exchange Commission ("SEC") for interim reporting. Accordingly, they do not include certain footnotes and financial presentations normally required under GAAP for complete financial statements. The condensed consolidated financial statements include the accounts of the Redwood Green, General Extract and CMI, a VIE for which the Company is deemed to be the primary beneficiary. All significant intercompany balances and transactions have been eliminated in consolidation. The Company operates as one segment from its corporate headquarters in Colorado. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements, with exception to the revision as described in Note 3 and reflect all adjustments, consisting of normal recurring adjustments, necessary to present fairly the financial position and the results of operations and cash flows. The results for the three- and six-month periods ended June 30, 2020 are not necessarily indicative of the results to be expected for any subsequent period or the entire year ending December 31, 2020. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company's annual audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company's Form 10-K filed on April 3, 2020 with the SEC. Use of Estimates The preparation of the Company's financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to determining the fair value of the assets acquired and liabilities assumed in acquisition, determining the fair value and potential impairment of inventory, determining the useful lives and potential impairment of long-lived assets and potential impairment of goodwill. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates. Reclassifications Certain items in the interim condensed consolidated financial statements were reclassified from prior periods for presentation purposes. Variable Interest Entities The Company accounts for variable interest entities in accordance with FASB ASC Topic 810, Consolidation Accounts Receivable, net Accounts receivable, net is comprised of balances due from customers and are recorded at the invoiced amount. Past due balances are determined based on the contractual terms of the arrangements. Accounts receivable are accrued against when management determines, after considering economic and business conditions and all means of collection efforts have been exhausted and the potential for recovery is considered remote, that the collection of receivables is doubtful. Accounts receivable amounts related to the VIE, net of allowance for doubtful accounts, were $36,847 and $113,599 as of June 30, 2020 and December 31, 2019, respectively. Uncollectible accounts previously recorded as receivables are recognized as bad debt expense, with a corresponding decrease to accounts receivable. Bad debt expense was $7,353 for the three and six months ended June 30, 2020. This amount includes $3,353 related to the VIE. There was no bad debt expense for the three and six months ending June 30, 2019. Inventory, net Inventory, net is comprised of work-in-process and finished goods consisting of cannabis and cannabidiol products. Cost includes expenditures directly related to the manufacturing process as well as suitable portions of related production overheads, based on normal operating capacity. Inventory, net is stated at the lower of cost or net realizable value. The Company compares the cost of inventory with market value and writes down inventories to net realizable value, if lower. In evaluating whether inventories are stated at lower of cost or net realizable value, management considers such factors as inventories on hand, physical deterioration, obsolescence, changes in price levels, estimated time to sell such inventories and current market conditions. Due to changing market conditions, management conducted a thorough review of its inventory. As a result, a provision for inventory losses of $0 and $400,787 was charged against cost of goods sold during the three and six months ended June 30, 2020, respectively, due to a write down of inventory to its net realizable value. This was based on the Company's best estimates of product sales prices and customer demand patterns. It is at least reasonably possible that the estimates used by the Company to determine its provision for inventory losses will be materially different from the actual amounts or results. These differences could result in materially higher than expected inventory provisions, which could have a materially adverse effect on the Company's results of operations and financial conditions in the near term. Revenue Recognition Under FASB Topic 606, Revenue from Contacts with Customers The Company's revenue consists of sales of cannabis and ancillary products to both retail consumers and wholesale customers. Revenue for retail customers is recognized upon completion of the transaction in the point of sale system and satisfaction of the sale by providing the corresponding inventory at the retail location. Revenue for wholesale customers is recognized upon acceptance of the physical goods and confirmation by acceptance of the inventory in the regulatory marijuana enforcement tracking reporting compliance ("METRC") system. Revenue is recognized upon transfer of control of promised products to customers, generally as risk of loss passes, in an amount that reflects the consideration the Company expects to receive in exchange for those products. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from revenue. Retail customer loyalty liabilities are recognized in the period in which they are incurred and will often be retired without being utilized. Shipping and handling costs are expensed as incurred and are included in cost of sales, which were not material for the three and six months ended June 30, 2020. The Company operates in a highly regulated environment in which state regulatory approval is required prior to the customer being able to purchase the product, either through the Colorado Marijuana Enforcement Division for wholesale clients or the Colorado Department of Public Health and Environment for medical patients. Stock-Based Compensation The fair value of restricted stock units ("RSUs") granted are measured on the grant date using the closing price of the Company's common shares on the grant date. The Company accounts for forfeitures as they occur, rather than estimating expected forfeitures over the course of a vesting period. All stock-based compensation costs are recorded in general and administrative expenses in the condensed consolidated statements of operations. Income Taxes The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes Comprehensive Loss ASC 220, Comprehensive Income Fair Value Measurements Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. ● Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The carrying values reported in the condensed consolidated balance sheets for cash, prepaid expenses, inventories, accounts payable, notes payable, and taxes payable approximate fair values because of the immediate or short-term maturities of these financial instruments. There were no other assets or liabilities that require fair value to be recalculated on a recurring basis. Net Loss per Share The Company follows ASC 260, Earnings Per Share Assets and Liabilities of Discontinued Operations Held for Sale In accordance with ASC 205-20-45, assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets (and liabilities) are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at the lower of their carrying value or fair value less costs to sell. Depreciation of assets ceases upon designation as held for sale. See Note 8.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2020
Revenue Recognition [Abstract]
Revenue Recognition	6. Revenue Recognition Disaggregated Revenue For the Three Months Ended 2020 2019 Types of Revenues: Medical retail (amounts related to VIE discontinued operations of $1,205,330 and $0) $ 1,205,330 $ - Medical wholesale (amounts related to VIE discontinued operations of $336,776 and $0) 336,776 - Recreational wholesale (amounts related to VIE discontinued operations of $204,871 and $0) 974,426 - Other revenues (amounts related to VIE discontinued operations of $0 and $0) - - Total revenues $ 2,516,532 $ - For the Six Months Ended 2020 2019 Types of Revenues: Medical retail (amounts related to VIE discontinued operations of $2,272,184 and $0) $ 2,283,384 $ - Medical wholesale (amounts related to VIE discontinued operations of $599,227 and $0) 599,927 - Recreational wholesale (amounts related to VIE discontinued operations of $454,715 and $0) 1,224,270 - Other revenues (amounts related to VIE discontinued operations of $2,741 and $0) 2,741 - Total revenues $ 4,110,322 $ -

Business Combination

Business Combination	6 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Business Combination	7. Business Combination Effective July 15, 2019, the Company acquired cannabis brands and other assets of CMI. In consideration of the sale and transfer of the acquired assets, the Company delivered 13,553,233 shares of Redwood Green common stock, in addition to $1,999,770 in cash to the members of CMI. The CMI Transaction was accounted for as a business combination in accordance with ASC 805, Business Combinations Cash $ 1,999,770 Common stock 6,776,617 Total purchase price $ 8,776,387 Description Fair Value Weighted Assets acquired: Cash $ 136,654 Other current assets 74 Property and equipment, net 1,985,738 Intangible assets: Customer relationships 215,900 6 Trademark/trade name 1,340,000 Indefinite Developed manufacturing process 1,330,000 Indefinite Goodwill 4,663,514 Right of use asset 1,411,461 Deposits 12,348 Total assets acquired $ 11,095,689 Liabilities assumed: Notes payable $ 147,268 Notes payable, related parties 760,573 Right of use liability 1,411,461 Total liabilities assumed 2,319,302 Estimated fair value of net assets acquired $ 8,776,387 Unaudited Pro Forma Results CMI contributed a net loss of $60,315 and $227,749 for the three and six months ended June 30, 2020, respectively, included in discontinued operations in the Company's consolidated statements of operations. The following table below represents the revenue, net loss and loss per share effect of the acquired company, as reported in our pro forma basis as if the acquisition occurred on January 1, 2019. These pro forma results are not necessarily indicative of the results that actually would have occurred if the acquisition had occurred on the first day of the periods presented, nor does the pro forma financial information purport to represent the results of operations for future periods. For the Three Months Ended For the Six Months Ended 2020 2019 2020 2019 Net Sales $ 2,516,532 $ 1,556,739 $ 4,110,322 $ 3,057,184 Net loss $ (773,008 ) $ (395,966 ) $ (4,370,317 ) $ (681,703 ) Net loss per common share $ (0.01 ) $ (0.00 ) $ (0.05 ) $ (0.01 )

Discontinued Operations

Discontinued Operations	6 Months Ended
	Jun. 30, 2020
Cash, Including Discontinued Operations [Abstract]
Discontinued Operations	8. Discontinued Operations In April 2019, the Company began to reposition itself into the cannabis industry. On July 1, 2019, the Company disposed of its Colombian subsidiary, Devco, in exchange for its acquisition of 100% of the membership units of General Extract. Devco's net assets primarily consisted of approximately 13 hectares of undeveloped land. The operations of the Colombian business and land were accounted for as discontinued operations through the date of divestiture. The accompanying condensed consolidated balance sheets include the following carrying amounts of assets and liabilities related to these Devco discontinued operations: June 30, July 1, Assets Cash $ - $ 18,472 Inventory, net - - Prepaid expenses and advances - 29,980 Current assets held for sale - 48,452 Property and equipment, net - 456,762 Total assets held for sale - 505,214 Liabilities Accounts payable and accrued liabilities - 23,123 Total liabilities held for sale - 23,123 Net assets $ - $ 482,091 * - Date of Devco disposition The condensed consolidated statements of operations include the following operating results related to these Devco discontinued operations: Three Months Ended Six Months Ended 2020 2019 2020 2019 Selling, marketing and administrative $ - $ (1,029 ) $ - $ 19,716 Impairment loss - (16 ) - 903 Interest expense - 79 - 310 Net loss from discontinued operations, before taxes - 966 - (20,929 ) Income taxes - (24 ) - 1,350 Net loss from discontinued operations, net of tax $ - $ 990 $ - $ (22,279 ) Foreign currency translation adjustments - (5,824 ) - (5,370 ) Comprehensive loss from discontinued operations, net of tax $ - $ (4,834 ) $ - $ (27,649 ) For the six months ended June 30, 2019, statements of cash flows include non-cash impairment charges of $903 and depreciation expense of $368 for the six months ended June 30, 2019 related to these Devco discontinued operations. In June 2020, the Company's board of directors adopted a plan to exit the cultivation, manufacturing of infused products and retail distribution businesses through the sale of Good Meds. The Company determined that the intended sale represented a strategic shift that will have a major effect on the Company's operations and financial results and therefore, for financial statement reporting purposes classified Good Meds and its consolidated VIE CMI as held for sale at June 30, 2020 and December 31, 2019. The accompanying condensed consolidated balance sheets include the following carrying amounts of assets and liabilities related to these CMI discontinued operations: June 30, December 31, Assets Accounts receivable, net $ 36,847 $ 113,599 Prepaid expenses 11,535 11,588 Inventory, net 820,320 768,633 Property and equipment, net 2,472,778 2,152,626 Goodwill 4,663,514 4,663,514 Intangible assets, net 2,851,313 2,869,247 Security deposits 15,608 15,608 Right of use asset, net 1,028,133 1,243,732 Total current assets held for sale 11,900,048 11,838,547 Total assets held for sale $ 11,900,048 $ 11,838,547 Liabilities Accounts payable and accrued expenses 259,450 337,386 Taxes payable 22,907 24,865 Notes payable, related parties 405,232 307,450 Right of use liability 1,022,500 1,243,732 Total liabilities held for sale 1,710,089 1,913,433 Net assets $ 10,189,959 $ 9,925,114 The condensed consolidated statements of operations include the following operating results related to these CMI discontinued operations: Three Months Ended Six Months Ended 2020 2019 2020 2019 Net sales $ 1,746,977 $ - $ 3,328,867 $ - Cost of goods sold, inclusive of depreciation 1,249,875 - 2,628,051 - Gross profit 497,102 - 700,816 - Operating expenses: Personnel costs 97,603 - 182,767 - Sales and marketing 276,554 - 474,698 - General and administrative 62,604 - 131,710 - Legal and professional fees 12,936 - 21,231 - Amortization expense 8,967 - 17,934 - Total operating expenses 458,664 - 828,340 - Gain / (loss) from operations 38,438 - (127,524 ) - Other income (expenses): Interest expense (98,753 ) - (100,225 ) - Loss on foreign exchange - - - - Total other expenses (98,753 ) - (100,225 ) - Net loss from discontinued operations, before taxes (60,315 ) - (227,749 ) - Income taxes - - - - Net loss from discontinued operations $ (60,315 ) $ - $ (227,749 ) $ -

Inventory, Net

Inventory, Net	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Inventory, Net	9. Inventory, Net Inventory, net consisted of the following: June 30, December 31, Finished goods (amounts related to VIE discontinued operations of $484,113 and $416,871) $ 484,113 $ 920,671 Work-in-process inventory grow (amounts related to VIE discontinued operations of $336,207 and $351,762) 336,207 351,762 Provision for inventory losses - (163,800 ) $ 820,320 $ 1,108,633 The Company re-negotiated the selling price of the cannabidiol finished goods inventory from General Extract in 2019 and 2020. All remaining cannabidiol finished goods inventory was sold in 2020 Q2. Finished goods relating to cannabis and cannabidiol products had balances of $484,113 and $0, respectively, as of June 30, 2020.

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	10. Property and Equipment, Net Property and equipment, net consisted of the following. All property and equipment is owned by CMI and classified as held for sale. June 30, December 31, Leasehold improvements $ 2,236,054 $ 2,223,609 Machinery and equipment 954,081 888,786 Furniture and fixtures 43,331 43,331 Construction in progress 632,137 258,615 3,865,603 3,414,341 Less: Accumulated depreciation (1,392,825 ) (1,261,715 ) $ 2,472,778 $ 2,152,626 Depreciation expense for the three and six months ended June 30, 2020 was $63,793, and $131,110, respectively, and was $0 and $368 for the three and six months ended June 30, 2019, respectively. Depreciation expense was recorded in cost of goods sold and general and administrative expense for the six months ended June 30, 2020 and 2019, respectively.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	11. Goodwill and Intangible Assets The Company tests goodwill and definite-lived intangible assets for impairment annually as of October 1st, or more frequently whenever events or changes in circumstances indicate that the asset might be impaired. There were no events or circumstances since December 31, 2019 requiring the Company to test for impairment of goodwill. The carrying value of goodwill was $4,663,514 as of June 30, 2020 and December 31, 2019 and is classified as held for sale. The following tables summarize information relating to the Company's identifiable intangible assets, which are classified as held for sale, as of June 30, 2020 and December 31, 2019: June 30, 2020 Estimated Gross Accumulated Carrying Amortized: Customer relationships 6 years $ 215,900 $ (34,587 ) $ 181,313 215,900 (34,587 ) 181,313 Indefinite-lived Trademark/trade name Indefinite 1,340,000 - 1,340,000 Developed manufacturing process Indefinite 1,330,000 - 1,330,000 $ 2,885,900 $ (34,587 ) $ 2,851,313 December 31, 2019 Estimated Gross Accumulated Carrying Amortized: Customer relationships 6 years $ 215,900 $ (16,653 ) $ 199,247 215,900 (16,653 ) 199,247 Indefinite-lived Trademark/trade name Indefinite 1,340,000 - 1,340,000 Developed manufacturing process Indefinite 1,330,000 - 1,330,000 $ 2,885,900 $ (16,653 ) $ 2,869,247 Amortization expense, which is included in discontinued operations, was $8,967 and $17,934 for the three and six months ended June 30, 2020, respectively, and was $0 for the three and six months ended June 30, 2019.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	12. Related Party Transactions In conjunction with the CMI Transaction, the Company assumed a note payable in which the note holder, John Knapp ("Knapp") is a significant shareholder in the Company. Additionally, Knapp is a former executive and board director, as well as current shareholder in PharmaCielo Ltd. ("PharmaCielo"), a supplier of naturally grown and processed medicinal-grade cannabis oil extracts. As of June 30, 2020, the outstanding balance of the notes payable, related party was $405,232. No terms have been agreed to between the Company and Knapp. The note is assumed to be due on demand. Effective February 25, 2020, Knapp resigned as a director of Redwood Green, at which time 200,000 Restricted Stock Units were deemed to have vested and were converted into 200,000 common shares. Refer to Note 2 for additional details on the relationship of CMI as a VIE. PharmaCielo is a large grower of hemp and producer of CBD isolate and other related products, based in Toronto, Canada, with operational headquarters in Colombia. The Company and PharmaCielo have had significant shareholders, executives and board members in common during their respective histories. During 2019 and the first quarter of 2020, a wholly owned subsidiary of the Company purchased raw material products from PharmaCielo Colombia Holdings S.A.S., a wholly owned subsidiary of PharmaCielo, for distribution in the United States. As of June 30, 2020, Redwood Green held no inventory purchased from PharmaCielo. The Company re-negotiated the selling price of the finished goods as of December 31, 2019, and again as of June 30, 2020, resulting in a $460,800 reduction in the original cost. Refer to Notes 5 and 9 for additional details on inventory.

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Shareholders' Equity	13. Shareholders' Equity In February 2020, the Company issued 400,000 shares of common stock pursuant to accelerated vesting of RSU's upon the resignation of a former executive. In February 2020, the Company issued 200,000 shares of common stock pursuant to accelerated vesting of RSU's upon the resignation of a former board member. In March 2020, the Company issued 1,175,549 shares of common stock to a former executive per a separation agreement. In June 2020, four shareholders submitted 15,050,000 shares of common stock for cancellation pursuant to prior agreements among certain shareholders. Accordingly, the Company cancelled 15,050,000 shares of common stock. Restricted Stock Unit Awards The Company adopted its 2019 Omnibus Stock Incentive Plan (the "2019 Plan"), which provides for the issuance of stock options, stock grants and RSUs to employees, directors and consultants. The primary purpose of the 2019 Plan is to enhance the ability to attract, motivate, and retain the services of qualified employees, officers and directors. Any RSUs granted under the 2019 Plan will be at the discretion of the Compensation Committee of the Board of Directors. A summary of the Company's RSU award activity for the six months ended June 30, 2020 is as follows: Restricted Weighted Outstanding at December 31, 2019 - $ - Granted 4,000,000 0.63 Vested (600,000 ) 0.65 Forfeited (200,000 ) 0.65 Outstanding at March 31, 2020 3,200,000 0.62 Granted 1,442,895 0.29 Vested (10,000 ) 0.28 Forfeited (2,000,000 ) 0.60 Outstanding at June 30, 2020 2,632,895 $ 0.46 The total fair value of RSUs vested during the three and six months ending June 30, 2020 was $2,750 and $392,810, respectively, and was $0 during the three and six months ending June 30, 2019. As of June 30, 2020, there was $987,249 of unrecognized stock-based compensation cost related to non-vested RSU's, which is expected to be recognized over the remaining vesting period. Stock-based compensation expense relating to RSU's was $58,842 and $608,431 for the three and six months ending June 30, 2020, respectively, and was $0 for the three and six months ended June 30, 2019. Stock-based compensation for the six months ending June 30, 2020 consisted of equity awards forfeited, granted and vested to employees, directors and consultants of the Company in the amount of $(59,091), $101,680, and $16,253, respectively. Expenses for stock-based compensation is included on the accompanying consolidated statements of operations in general and administrative expense.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	14. Income Taxes In accordance with ASC 740-270, the Company calculates the interim tax expense based on an annual effective tax rate ("AETR"). The AETR represents the Company's estimated effective tax rate for the year based on full year projection of tax expense, divided by the projection of full year pretax book loss, adjusted for discrete transactions occurring during the period. The annual effective tax rates for the six months ended June 30, 2020 was (0.12%). The Company's annual effective tax rate for the six months ended June 30, 2020 is lower than the federal statutory tax rate of 21% primarily due to the disallowance of Company expenses due to Internal Revenue Code Section 280(E) coupled with the increase in future deductible tax differences not expected to be realized in future periods. For the period ending June 30, 2020, the Company has recorded a total income tax liability in the amount of $5,117. This number represents the actual pretax book income generated for the six-month period ended June 30, 2020 multiplied by the AETR noted above. The total income tax liability recorded is in relation to the discontinued operations of the company and available for sale assets. For the three and six months ended June 30, 2020, the Company has a net operating loss carry forward of approximately $951,113 and $583,001, respectively. Utilization of these net loss carry forwards is subject to the limitations of Internal Revenue Code Section 382. The Company applied a 100% valuation reserve against the deferred tax benefit as the realization of the benefit is not certain.

Commitments & Contingencies

Commitments & Contingencies	6 Months Ended
	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	15. Commitments & Contingencies Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company's condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Lease Commitments The Company accounts for lease transactions in accordance with Topic 842, Leases There are no other leases that meet the reporting standards of ASU Topic 842 as the Company does not have any other leases with a term exceeding twelve months. Other lease payments not accounted for under ASU Topic 842 total $14,229 and $35,887 for the three and six months ended June 30, 2020, respectively. An ROU asset of $1,411,461 was recognized upon the CMI Transaction. While no cash payments were made for operating lease liabilities subsequent to the acquisition of CMI, the present value of the liabilities decreased by $115,463 and $221,232 for the three and six months ended June 30, 2020, respectively. This balance is included in the operating section of the statement of cash flows for the six months ended June 30, 2020. Operating lease cost was approximately $156,708 and $308,082 for the three and six months ended June 30, 2020, respectively. The Company does not have any leases that have not yet commenced which are significant. Legal Proceedings We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	16. Subsequent Events Effective July 20, 2020, Christopher Hansen joined the company as Chief Executive Officer. On August 4, 2020, the Company received $250,000 in consideration for the sale of securities consisting of 250,000 shares of common stock and warrants exercisable into an additional 250,000 shares of common stock exercisable at a price of $0.25 per share with an expiration of twenty-four months from date of subscription. In August 2020, the Company accepted share subscriptions from three individuals and issued 60,000 shares for gross proceeds of $15,000. In August, 2020, the Company issued a Convertible Term Note to John Knapp to formalize the terms of an advance in the amount of $307,450 made by John Knapp to Critical Mass Industries LLC on March 19, 2019. The Note bears interest on an annual basis of 25% and is convertible into shares of common stock at a price of $0.25 per share. The Note matures on January 31, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information and with the Securities and Exchange Commission ("SEC") for interim reporting. Accordingly, they do not include certain footnotes and financial presentations normally required under GAAP for complete financial statements. The condensed consolidated financial statements include the accounts of the Redwood Green, General Extract and CMI, a VIE for which the Company is deemed to be the primary beneficiary. All significant intercompany balances and transactions have been eliminated in consolidation. The Company operates as one segment from its corporate headquarters in Colorado. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements, with exception to the revision as described in Note 3 and reflect all adjustments, consisting of normal recurring adjustments, necessary to present fairly the financial position and the results of operations and cash flows. The results for the three- and six-month periods ended June 30, 2020 are not necessarily indicative of the results to be expected for any subsequent period or the entire year ending December 31, 2020. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company's annual audited financial statements and notes thereto for the year ended December 31, 2019, included in the Company's Form 10-K filed on April 3, 2020 with the SEC.
Use of Estimates	Use of Estimates The preparation of the Company's financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to determining the fair value of the assets acquired and liabilities assumed in acquisition, determining the fair value and potential impairment of inventory, determining the useful lives and potential impairment of long-lived assets and potential impairment of goodwill. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.
Reclassifications	Reclassifications Certain items in the interim condensed consolidated financial statements were reclassified from prior periods for presentation purposes.
Variable Interest Entities	Variable Interest Entities The Company accounts for variable interest entities in accordance with FASB ASC Topic 810, Consolidation
Accounts Receivable, net	Accounts Receivable, net Accounts receivable, net is comprised of balances due from customers and are recorded at the invoiced amount. Past due balances are determined based on the contractual terms of the arrangements. Accounts receivable are accrued against when management determines, after considering economic and business conditions and all means of collection efforts have been exhausted and the potential for recovery is considered remote, that the collection of receivables is doubtful. Accounts receivable amounts related to the VIE, net of allowance for doubtful accounts, were $36,847 and $113,599 as of June 30, 2020 and December 31, 2019, respectively. Uncollectible accounts previously recorded as receivables are recognized as bad debt expense, with a corresponding decrease to accounts receivable. Bad debt expense was $7,353 for the three and six months ended June 30, 2020. This amount includes $3,353 related to the VIE. There was no bad debt expense for the three and six months ending June 30, 2019.
Inventory, net	Inventory, net Inventory, net is comprised of work-in-process and finished goods consisting of cannabis and cannabidiol products. Cost includes expenditures directly related to the manufacturing process as well as suitable portions of related production overheads, based on normal operating capacity. Inventory, net is stated at the lower of cost or net realizable value. The Company compares the cost of inventory with market value and writes down inventories to net realizable value, if lower. In evaluating whether inventories are stated at lower of cost or net realizable value, management considers such factors as inventories on hand, physical deterioration, obsolescence, changes in price levels, estimated time to sell such inventories and current market conditions. Due to changing market conditions, management conducted a thorough review of its inventory. As a result, a provision for inventory losses of $0 and $400,787 was charged against cost of goods sold during the three and six months ended June 30, 2020, respectively, due to a write down of inventory to its net realizable value. This was based on the Company's best estimates of product sales prices and customer demand patterns. It is at least reasonably possible that the estimates used by the Company to determine its provision for inventory losses will be materially different from the actual amounts or results. These differences could result in materially higher than expected inventory provisions, which could have a materially adverse effect on the Company's results of operations and financial conditions in the near term.
Revenue Recognition	Revenue Recognition Under FASB Topic 606, Revenue from Contacts with Customers The Company's revenue consists of sales of cannabis and ancillary products to both retail consumers and wholesale customers. Revenue for retail customers is recognized upon completion of the transaction in the point of sale system and satisfaction of the sale by providing the corresponding inventory at the retail location. Revenue for wholesale customers is recognized upon acceptance of the physical goods and confirmation by acceptance of the inventory in the regulatory marijuana enforcement tracking reporting compliance ("METRC") system. Revenue is recognized upon transfer of control of promised products to customers, generally as risk of loss passes, in an amount that reflects the consideration the Company expects to receive in exchange for those products. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from revenue. Retail customer loyalty liabilities are recognized in the period in which they are incurred and will often be retired without being utilized. Shipping and handling costs are expensed as incurred and are included in cost of sales, which were not material for the three and six months ended June 30, 2020. The Company operates in a highly regulated environment in which state regulatory approval is required prior to the customer being able to purchase the product, either through the Colorado Marijuana Enforcement Division for wholesale clients or the Colorado Department of Public Health and Environment for medical patients.
Stock-Based Compensation	Stock-Based Compensation The fair value of restricted stock units ("RSUs") granted are measured on the grant date using the closing price of the Company's common shares on the grant date. The Company accounts for forfeitures as they occur, rather than estimating expected forfeitures over the course of a vesting period. All stock-based compensation costs are recorded in general and administrative expenses in the condensed consolidated statements of operations.
Income Taxes	Income Taxes The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes
Comprehensive Loss	Comprehensive Loss ASC 220, Comprehensive Income
Fair Value Measurements	Fair Value Measurements Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. ● Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The carrying values reported in the condensed consolidated balance sheets for cash, prepaid expenses, inventories, accounts payable, notes payable, and taxes payable approximate fair values because of the immediate or short-term maturities of these financial instruments. There were no other assets or liabilities that require fair value to be recalculated on a recurring basis.
Net Loss per Share	Net Loss per Share The Company follows ASC 260, Earnings Per Share
Assets and Liabilities of Discontinued Operations Held for Sale	Assets and Liabilities of Discontinued Operations Held for Sale In accordance with ASC 205-20-45, assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets (and liabilities) are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at the lower of their carrying value or fair value less costs to sell. Depreciation of assets ceases upon designation as held for sale. See Note 8.

Variable Interest Entity (Table

Variable Interest Entity (Tables)	6 Months Ended
	Jun. 30, 2020
Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract]
Schedule of Variable Interest Entity	Description As of June 30, As of Current assets Cash and cash equivalents $ 258,703 $ 467,460 Accounts receivable, net 36,847 113,599 Inventory, net 820,320 768,633 Total current assets 1,115,870 1,349,692 Total assets $ 1,115,870 $ 1,349,692 Current liabilities Accounts payable and accrued expenses $ 259,450 $ 337,386 Total current liabilities 259,450 337,386 Total liabilities 259,450 337,386 Net assets $ 856,420 $ 1,012,306
Schedule of description of operating results of Variable Interest Entities	Description For the Three Months Ended For the Six Months Ended Net sales $ 1,746,977 $ 3,328,867 Cost of goods sold, inclusive of depreciation 1,249,875 2,628,051 Gross profit $ 497,102 $ 700,816 Operating expenses Personnel costs 97,603 182,767 Sales and marketing 276,554 474,698 General and administrative 62,604 131,710 Legal and professional fees 12,936 21,231 Amortization expense 8,967 17,934 Total operating expenses 458,664 828,340 Gain from operations $ 38,438 $ (127,524 ) Interest expense 98,753 100,225 Total other expenses 98,753 100,225 Net income $ (60,315 ) $ (227,749 )

Revision of Prior Period Fina_2

Revision of Prior Period Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2020
Revision of Prior Period Financial Statements [Abstract]
Schedule of impact of these adjustments on consolidated financial statements	December 31, 2019 Previously Non-controlling Revised (1) Inventory, net (2) $ 340,000 $ 768,633 $ 1,108,633 Accounts receivable, net (2) $ - $ 113,599 $ 113,599 Total current assets $ 3,933,047 $ 882,232 $ 4,815,279 Goodwill $ 5,855,748 $ (1,192,234 ) $ 4,663,514 Total assets $ 16,070,008 $ (310,002 ) $ 15,760,006 Accounts payable and accrued expenses $ 754,850 $ 337,386 $ 1,092,236 Total current liabilities $ 1,558,821 $ 337,386 $ 1,896,207 Total liabilities $ 2,335,588 $ 337,386 $ 2,672,974 Additional paid-in capital $ 16,246,645 $ 647,458 $ 16,894,103 Non-controlling interests in consolidated variable interest entity $ 1,294,846 $ (1,294,846 ) $ - Total shareholders' equity $ 13,734,420 $ (647,388 ) $ 13,087,032 Total liabilities and shareholders' equity $ 16,070,008 $ (310,002 ) $ 15,760,006 (1) There was no impact to the Company's consolidated statements of operations. (2) The Company does not own the VIE's portion of this asset. Amounts relating to the VIE are accounts receivable, net of $113,599 and inventory, net of $768,633.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2020
Revenue Recognition [Abstract]
Schedule of disaggregated revenue	For the Three Months Ended 2020 2019 Types of Revenues: Medical retail (amounts related to VIE discontinued operations of $1,205,330 and $0) $ 1,205,330 $ - Medical wholesale (amounts related to VIE discontinued operations of $336,776 and $0) 336,776 - Recreational wholesale (amounts related to VIE discontinued operations of $204,871 and $0) 974,426 - Other revenues (amounts related to VIE discontinued operations of $0 and $0) - - Total revenues $ 2,516,532 $ - For the Six Months Ended 2020 2019 Types of Revenues: Medical retail (amounts related to VIE discontinued operations of $2,272,184 and $0) $ 2,283,384 $ - Medical wholesale (amounts related to VIE discontinued operations of $599,227 and $0) 599,927 - Recreational wholesale (amounts related to VIE discontinued operations of $454,715 and $0) 1,224,270 - Other revenues (amounts related to VIE discontinued operations of $2,741 and $0) 2,741 - Total revenues $ 4,110,322 $ -

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Schedule of business acquisitions	Cash $ 1,999,770 Common stock 6,776,617 Total purchase price $ 8,776,387 Description Fair Value Weighted Assets acquired: Cash $ 136,654 Other current assets 74 Property and equipment, net 1,985,738 Intangible assets: Customer relationships 215,900 6 Trademark/trade name 1,340,000 Indefinite Developed manufacturing process 1,330,000 Indefinite Goodwill 4,663,514 Right of use asset 1,411,461 Deposits 12,348 Total assets acquired $ 11,095,689 Liabilities assumed: Notes payable $ 147,268 Notes payable, related parties 760,573 Right of use liability 1,411,461 Total liabilities assumed 2,319,302 Estimated fair value of net assets acquired $ 8,776,387
Schedule of pro forma financial information	For the Three Months Ended For the Six Months Ended 2020 2019 2020 2019 Net Sales $ 2,516,532 $ 1,556,739 $ 4,110,322 $ 3,057,184 Net loss $ (773,008 ) $ (395,966 ) $ (4,370,317 ) $ (681,703 ) Net loss per common share $ (0.01 ) $ (0.00 ) $ (0.05 ) $ (0.01 )

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2020
Cash, Including Discontinued Operations [Abstract]
Schedule of discontinued operations carrying amounts of assets and liabilities	June 30, July 1, Assets Cash $ - $ 18,472 Inventory, net - - Prepaid expenses and advances - 29,980 Current assets held for sale - 48,452 Property and equipment, net - 456,762 Total assets held for sale - 505,214 Liabilities Accounts payable and accrued liabilities - 23,123 Total liabilities held for sale - 23,123 Net assets $ - $ 482,091 * - Date of Devco disposition June 30, December 31, Assets Accounts receivable, net $ 36,847 $ 113,599 Prepaid expenses 11,535 11,588 Inventory, net 820,320 768,633 Property and equipment, net 2,472,778 2,152,626 Goodwill 4,663,514 4,663,514 Intangible assets, net 2,851,313 2,869,247 Security deposits 15,608 15,608 Right of use asset, net 1,028,133 1,243,732 Total current assets held for sale 11,900,048 11,838,547 Total assets held for sale $ 11,900,048 $ 11,838,547 Liabilities Accounts payable and accrued expenses 259,450 337,386 Taxes payable 22,907 24,865 Notes payable, related parties 405,232 307,450 Right of use liability 1,022,500 1,243,732 Total liabilities held for sale 1,710,089 1,913,433 Net assets $ 10,189,959 $ 9,925,114
Schedule of discontinued operations statements of operations	Three Months Ended Six Months Ended 2020 2019 2020 2019 Selling, marketing and administrative $ - $ (1,029 ) $ - $ 19,716 Impairment loss - (16 ) - 903 Interest expense - 79 - 310 Net loss from discontinued operations, before taxes - 966 - (20,929 ) Income taxes - (24 ) - 1,350 Net loss from discontinued operations, net of tax $ - $ 990 $ - $ (22,279 ) Foreign currency translation adjustments - (5,824 ) - (5,370 ) Comprehensive loss from discontinued operations, net of tax $ - $ (4,834 ) $ - $ (27,649 ) Three Months Ended Six Months Ended 2020 2019 2020 2019 Net sales $ 1,746,977 $ - $ 3,328,867 $ - Cost of goods sold, inclusive of depreciation 1,249,875 - 2,628,051 - Gross profit 497,102 - 700,816 - Operating expenses: Personnel costs 97,603 - 182,767 - Sales and marketing 276,554 - 474,698 - General and administrative 62,604 - 131,710 - Legal and professional fees 12,936 - 21,231 - Amortization expense 8,967 - 17,934 - Total operating expenses 458,664 - 828,340 - Gain / (loss) from operations 38,438 - (127,524 ) - Other income (expenses): Interest expense (98,753 ) - (100,225 ) - Loss on foreign exchange - - - - Total other expenses (98,753 ) - (100,225 ) - Net loss from discontinued operations, before taxes (60,315 ) - (227,749 ) - Income taxes - - - - Net loss from discontinued operations $ (60,315 ) $ - $ (227,749 ) $ -

Inventory, Net (Tables)

Inventory, Net (Tables)	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Schedule of inventory	June 30, December 31, Finished goods (amounts related to VIE discontinued operations of $484,113 and $416,871) $ 484,113 $ 920,671 Work-in-process inventory grow (amounts related to VIE discontinued operations of $336,207 and $351,762) 336,207 351,762 Provision for inventory losses - (163,800 ) $ 820,320 $ 1,108,633

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of property and equipment, net	June 30, December 31, Leasehold improvements $ 2,236,054 $ 2,223,609 Machinery and equipment 954,081 888,786 Furniture and fixtures 43,331 43,331 Construction in progress 632,137 258,615 3,865,603 3,414,341 Less: Accumulated depreciation (1,392,825 ) (1,261,715 ) $ 2,472,778 $ 2,152,626

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of identifiable intangible assets	June 30, 2020 Estimated Gross Accumulated Carrying Amortized: Customer relationships 6 years $ 215,900 $ (34,587 ) $ 181,313 215,900 (34,587 ) 181,313 Indefinite-lived Trademark/trade name Indefinite 1,340,000 - 1,340,000 Developed manufacturing process Indefinite 1,330,000 - 1,330,000 $ 2,885,900 $ (34,587 ) $ 2,851,313 December 31, 2019 Estimated Gross Accumulated Carrying Amortized: Customer relationships 6 years $ 215,900 $ (16,653 ) $ 199,247 215,900 (16,653 ) 199,247 Indefinite-lived Trademark/trade name Indefinite 1,340,000 - 1,340,000 Developed manufacturing process Indefinite 1,330,000 - 1,330,000 $ 2,885,900 $ (16,653 ) $ 2,869,247

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Schedule of the company's RSU award activity	Restricted Weighted Outstanding at December 31, 2019 - $ - Granted 4,000,000 0.63 Vested (600,000 ) 0.65 Forfeited (200,000 ) 0.65 Outstanding at March 31, 2020 3,200,000 0.62 Granted 1,442,895 0.29 Vested (10,000 ) 0.28 Forfeited (2,000,000 ) 0.60 Outstanding at June 30, 2020 2,632,895 $ 0.46

Nature of the Business (Details

Nature of the Business (Details) - USD ($)	Jul. 15, 2019	Jun. 30, 2020	Jul. 02, 2019
Nature of the Business (Textual)
Denver, CO, operates square-foot, description		Good Meds, the operating unit of CMI, is based in Denver, CO, and operates in a 60,000-square-foot cultivation and processing facility.
Critical Mass Industries [Member]
Nature of the Business (Textual)
Shares issued	1,500,000
Cash paid	$ 1,999,770
General Extract, LLC [Member]
Nature of the Business (Textual)
Membership interests acquired			100.00%
First Coumbia Devco S.A.S [Member] | Critical Mass Industries [Member]
Nature of the Business (Textual)
Shares issued	13,553,233

Variable Interest Entity (Detai

Variable Interest Entity (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 611,863	$ 3,473,770	$ 3,120,845	$ 207,313
Inventory, net		340,000
Total current assets	13,408,751	15,760,006
Current liabilities
Total current liabilities	3,314,263	2,668,283
VIE's [Member]
Current assets
Cash and cash equivalents	258,703	467,460
Accounts receivable, net	36,847	113,599
Inventory, net	820,320	768,633
Total current assets	1,115,870	1,349,692
Total assets	1,115,870	1,349,692
Current liabilities
Accounts payable and accrued expenses	259,450	337,386
Total current liabilities	259,450	337,386
Total liabilities	259,450	337,386
Net assets	$ 856,420	$ 1,012,306

Variable Interest Entity (Det_2

Variable Interest Entity (Details 1) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Variable Interest Entity [Line Items]
Net sales	$ 769,555				$ 781,455
Cost of goods sold, inclusive of depreciation	310,695				744,279
Gross profit	458,860				37,176
Operating expenses
Personnel costs	687,573				1,416,685
Sales and marketing	237				14,854
General and administrative	219,054		222,238		1,799,762	269,860
Legal and professional fees	243,561				927,315
Total operating expenses	1,150,425		222,238		4,158,616	269,860
Gain from operations	(691,565)		(222,238)		(4,121,440)	(269,860)
Total other expenses	(16,011)		16		(16,011)	(430)
Net income	(773,008)	$ (3,597,309)	$ (221,231)	$ (70,884)	(4,370,317)	$ (292,569)
VIE's [Member]
Variable Interest Entity [Line Items]
Net sales	1,746,977				3,328,867
Cost of goods sold, inclusive of depreciation	1,249,875				2,628,051
Gross profit	497,102				700,816
Operating expenses
Personnel costs	97,603				182,767
Sales and marketing	276,554				474,698
General and administrative	62,604				131,710
Legal and professional fees	12,936				21,231
Amortization expense	8,967				17,934
Total operating expenses	458,664				828,340
Gain from operations	38,438				(127,524)
Interest expense	98,753				100,225
Total other expenses	98,753				100,225
Net income	$ (60,315)				$ (227,749)

Revision of Prior Period Fina_3

Revision of Prior Period Financial Statements (Details) - USD ($)		Jun. 30, 2020	Dec. 31, 2019
Inventory, net			$ 340,000
Accounts receivable, net		720,000
Total current assets		13,408,751	15,760,006
Goodwill		4,663,514	4,663,514
Total assets		13,408,751	15,760,006
Accounts payable and accrued expenses		1,603,403	754,850
Total current liabilities		3,314,263	2,668,283
Total liabilities		3,319,380	2,672,974
Additional paid-in capital		18,264,983	16,894,103
Total shareholders' equity		10,089,371	13,087,032
Total liabilities and shareholders' equity		$ 13,408,751	15,760,006
Previously Reported [Member]
Inventory, net	[1]		340,000
Accounts receivable, net	[1]
Total current assets			3,933,047
Goodwill			5,855,748
Total assets			16,070,008
Accounts payable and accrued expenses			754,850
Total current liabilities			1,558,821
Total liabilities			2,335,588
Additional paid-in capital			16,246,645
Non-controlling interests in consolidated variable interest entity			1,294,846
Total shareholders' equity			13,734,420
Total liabilities and shareholders' equity			16,070,008
Non-controlling Interest Adjustment [Member]
Inventory, net	[1]		768,633
Accounts receivable, net	[1]		113,599
Total current assets			882,232
Goodwill			1,192,234
Total assets			(310,002)
Accounts payable and accrued expenses			337,386
Total current liabilities			337,386
Total liabilities			337,386
Additional paid-in capital			647,458
Non-controlling interests in consolidated variable interest entity			(1,294,846)
Total shareholders' equity			(647,388)
Total liabilities and shareholders' equity			(310,002)
Revised [Member]
Inventory, net	[1],[2]		1,108,633
Accounts receivable, net	[1],[2]		113,599
Total current assets	[2]		4,815,279
Goodwill	[2]		4,663,514
Total assets	[2]		15,760,006
Accounts payable and accrued expenses	[2]		1,092,236
Total current liabilities	[2]		1,896,207
Total liabilities	[2]		2,672,974
Additional paid-in capital	[2]		16,894,103
Non-controlling interests in consolidated variable interest entity	[2]
Total shareholders' equity	[2]		13,087,032
Total liabilities and shareholders' equity	[2]		$ 15,760,006
[1]	The Company does not own the VIE's portion of this asset. Amounts relating to the VIE are accounts receivable, net of $113,599 and inventory, net of $768,633.
[2]	There was no impact to the Company's consolidated statements of operations.

Revision of Prior Period Fina_4

Revision of Prior Period Financial Statements (Details Textual) - USD ($)		Jun. 30, 2020	Dec. 31, 2019
Revision of Prior Period Financial Statements (Textual)
Inventory, net			$ 340,000
Accounts receivable, net		720,000
Decrease in goodwill		4,663,514	4,663,514
Increase in additional-paid-in capital		18,264,983	16,894,103
VIE's [Member]
Revision of Prior Period Financial Statements (Textual)
Inventory, net		820,320	768,633
Accounts receivable, net		113,599
Accounts payable and accrued expenses		$ 259,450	337,386
Non-controlling Interest Adjustment [Member]
Revision of Prior Period Financial Statements (Textual)
Inventory, net	[1]		768,633
Accounts receivable, net	[1]		113,599
Decrease in goodwill			1,192,234
Increase in additional-paid-in capital			647,458
Accounts payable and accrued expenses			$ 337,386
[1]	The Company does not own the VIE's portion of this asset. Amounts relating to the VIE are accounts receivable, net of $113,599 and inventory, net of $768,633.

Going Concern Uncertainty, Fi_2

Going Concern Uncertainty, Financial Conditions and Management's Plans (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Going Concern Uncertainty, Financial Condition and Management's Plans (Textual)
Cash for operating activities					$ (2,410,645)	$ (192,330)
Accumulated deficit	$ (8,283,604)				(8,283,604)		$ (3,913,287)
Net loss	$ (773,008)	$ (3,597,309)	$ (221,231)	$ (70,884)	$ (4,370,317)	$ (292,569)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Summary of Significant Accounting Policies (Textual)
Accounts receivable, net	$ 720,000	$ 720,000
Provision for inventory losses	0	$ 400,787
Income taxes, description		In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy will be to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements.
Unvested RSU's considered potentially dilutive securities outstanding		2,632,895
Bad debt expense	7,353	$ 7,353
Variable Interest Entity, Primary Beneficiary [Member]
Summary of Significant Accounting Policies (Textual)
Accounts receivable, net				$ 113,599
Bad debt expense		$ 3,353

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Total revenues	$ 769,555		$ 781,455
Medical retail [Member]
Total revenues	1,205,330		2,283,384
Medical Wholesale [Member]
Total revenues	336,776		599,927
Recreational wholesale [Member]
Total revenues	974,426		1,224,270
Other revenues [Member]
Total revenues			$ 2,741

Revenue Recognition (Details Te

Revenue Recognition (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Other revenues [Member]
Revenue Recognition (Textual)
Amounts related to VIE	$ 0	$ 0	$ 2,741	$ 0
Recreational wholesale [Member]
Revenue Recognition (Textual)
Amounts related to VIE	204,871	0	454,715	0
Medical Wholesale [Member]
Revenue Recognition (Textual)
Amounts related to VIE	336,776	0	599,227	0
Medical retail [Member]
Revenue Recognition (Textual)
Amounts related to VIE	$ 1,205,330	$ 0	$ 2,272,184	$ 0

Business Combination (Details)

Business Combination (Details) - C M I Transaction [Member]	6 Months Ended
	Jun. 30, 2020USD ($)
Cash	$ 1,999,770
Common stock	6,776,617
Total purchase price	$ 8,776,387

Business Combination (Details 1

Business Combination (Details 1) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Intangible assets:
Goodwill	$ 4,663,514	$ 4,663,514
Trademark/trade name [Member]
Liabilities assumed:
Weighted average useful life	Indefinite
Developed manufacturing process [Member]
Liabilities assumed:
Weighted average useful life	Indefinite
Customer Relationships [Member]
Liabilities assumed:
Weighted average useful life (in years)	6 years	6 years
C M I Transaction [Member]
Assets acquired:
Cash	$ 136,654
Other current assets	74
Property and equipment, net	1,985,738
Intangible assets:
Customer relationships	215,900
Trademark/trade name	1,340,000
Developed manufacturing process	1,330,000
Goodwill	4,663,514
Right of use asset	1,411,461
Deposits	12,348
Total assets acquired	11,095,689
Liabilities assumed:
Notes payable	147,268
Notes payable, related parties	760,573
Right of use liability	1,411,461
Total liabilities assumed	2,319,302
Estimated fair value of net assets acquired	$ 8,776,387

Business Combination (Details 2

Business Combination (Details 2) - C M I Transaction [Member] - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Net Sales	$ 2,516,532	$ 1,556,739	$ 4,110,322	$ 3,057,184
Net loss	$ (773,008)	$ (395,966)	$ (4,370,317)	$ (681,703)
Net loss per common share	$ (0.01)	$ 0	$ (0.05)	$ (0.01)

Business Combination (Details T

Business Combination (Details Textual) - USD ($)	Jul. 15, 2019	Jun. 30, 2020	Jun. 30, 2020
C M I Transaction [Member]
Business Combination (Textual)
Number of common stock issued	13,553,233
Cash			$ 1,999,770
Net income		$ 60,315	$ 227,749
Critical Mass Industries [Member]
Business Combination (Textual)
Number of common stock issued	1,500,000
Cash	$ 1,999,770

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019	Jul. 02, 2019	[1]
C M I Transaction [Member]
Assets
Accounts receivable, net	$ 36,847	$ 113,599
Prepaid expenses	11,535	11,588
Inventory, net	820,320	768,633
Property and equipment, net current	2,472,778	2,152,626
Goodwill	4,663,514	4,663,514
Intangible assets, net	2,851,313	2,869,247
Security deposits	15,608	15,608
Right of use asset, net	1,028,133	1,243,732
Total current assets held for sale	11,900,048	11,838,547
Total assets held for sale	11,900,048	11,838,547
Liabilities
Accounts payable and accrued expenses	259,450	337,386
Taxes payable	22,907	22,907
Notes payable, related parties	405,232	307,450
Right of use liability	1,022,500	1,243,732
Total liabilities held for sale		1,913,433
Net assets	10,189,959	$ 9,925,114
First Colombia Devco Sas [Member]
Assets
Cash			$ 18,472
Prepaid expenses			29,980
Inventory, net
Total current assets held for sale			48,452
Property and equipment, net non current			456,762
Total assets held for sale			505,214
Liabilities
Accounts payable and accrued expenses			23,123
Total liabilities held for sale			23,123
Net assets			$ 482,091
[1]	Date of Devco disposition

Discontinued Operations (Deta_2

Discontinued Operations (Details 1) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Other income (expenses):
Loss on foreign exchange		$ (5,824)		$ (5,370)
C M I Transaction [Member]
Net sales	1,746,977		3,328,867
Cost of goods sold, inclusive of depreciation	3,328,867		2,628,051
Gross profit	497,102		700,816
Operating expenses:
Personnel costs	97,603		182,767
Sales and marketing	276,554		474,698
General and administrative	62,604		131,710
Legal and professional fees	(98,753)		21,231
Amortization expense	8,967		17,934
Total operating expenses	17,934		828,340
Gain / (loss) from operations	38,438		(127,524)
Other income (expenses):
Interest expense	(98,753)		(100,225)
Loss on foreign exchange
Total other expenses	(98,753)		(100,225)
Net loss from discontinued operations, before taxes	(60,315)		(227,749)
Income taxes
Net loss from discontinued operations, net of tax	(60,315)		(227,749)
First Colombia Devco Sas [Member]
Operating expenses:
Sales and marketing		(1,029)		19,716
Impairment loss		(16)		903
Other income (expenses):
Interest expense		79		310
Net loss from discontinued operations, before taxes		966		(20,929)
Income taxes		(24)		1,350
Net loss from discontinued operations, net of tax		990		(22,279)
Foreign currency translation adjustments		(5,824)		(5,370)
Comprehensive loss from discontinued operations, net of tax		$ (4,834)		$ (27,649)

Discontinued Operations (Deta_3

Discontinued Operations (Details Textual)	6 Months Ended
	Jun. 30, 2020USD ($)	Jul. 02, 2019ha
General Extract [Member]
Discontinued Operations (Textual)
Membership interests acquired		100.00%
First Colombia Devco Sas [Member]
Discontinued Operations (Textual)
Area of Land | ha		13
Discontinued operations non-cash impairment charges	$ 903
Discontinued operations depreciation expense	$ 368

Inventory, Net (Details)

Inventory, Net (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 484,113	$ 920,671
Work-in-process	336,207	351,762
Provision for inventory losses		(163,800)
Total inventory		$ 340,000

Inventory, Net (Details Textual

Inventory, Net (Details Textual) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Inventory, Net (Textual)
Finished goods amounts	$ 484,113	$ 920,671
Work-in-process inventory grow amounts	336,207	351,762
Variable Interest Entity, Primary Beneficiary [Member]
Inventory, Net (Textual)
Finished goods amounts	484,113	416,871
Work-in-process inventory grow amounts	336,207	$ 351,762
Cannabis [Member]
Inventory, Net (Textual)
Finished goods amounts	484,113
Cannabidiol [Member]
Inventory, Net (Textual)
Finished goods amounts	$ 0

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,865,603	$ 3,414,341
Less: Accumulated depreciation	(1,392,825)	(1,261,715)
Property and equipment, net	2,472,778	2,152,626
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	43,331	43,331
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,236,054	2,223,609
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	954,081	888,786
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 632,137	$ 258,615

Property and Equipment, Net (_2

Property and Equipment, Net (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Property and Equipment, Net (Textual)
Depreciation expense	$ 63,793	$ 0	$ 131,110	$ 368

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Indefinite-lived Intangible Assets [Line Items]
Amortized intangible assets, gross amount	$ 215,900	$ 215,900
Amortized intangible assets, accumulated amortization	(34,587)	(16,653)
Amortized intangible assets, carrying value	181,313	199,247
Indefinite lived Intangible assets, gross amount	2,885,900	2,885,900
Indefinite lived Intangible assets, accumulated amortization	34,587	16,653
Indefinite lived intangible assets, carrying value	2,851,313	2,869,247
Trademark/trade name [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite lived Intangible assets, gross amount	1,340,000	1,340,000
Indefinite lived Intangible assets, accumulated amortization
Indefinite lived intangible assets, carrying value	$ 1,340,000	$ 1,340,000
Indefinite lived intangible assets, estimated useful life (years)	Indefinite	Indefinite
Developed manufacturing process [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite lived Intangible assets, gross amount	$ 1,330,000	$ 1,330,000
Indefinite lived Intangible assets, accumulated amortization
Indefinite lived intangible assets, carrying value	$ 1,330,000	$ 1,330,000
Indefinite lived intangible assets, estimated useful life (years)	Indefinite	Indefinite
Customer relationships [Member]
Indefinite-lived Intangible Assets [Line Items]
Amortized intangible assets, gross amount	$ 215,900	$ 215,900
Amortized intangible assets, accumulated amortization	(34,587)	(16,653)
Amortized intangible assets, carrying value	$ 181,313	$ 199,247
Amortized intangible assets, estimated useful life (years)	6 years	6 years

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense including discontinued operations	$ 8,967	$ 0	$ 17,934	$ 0
Goodwill	$ 4,663,514		$ 4,663,514		$ 4,663,514

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Related Party Transactions (Textual)
Amount due to related party	$ 405,232
Maturity date	Feb. 25, 2020
Original cost	$ 460,800	$ 460,800
Converted into common shares	200,000
Restricted Stock Units (RSUs) [Member]
Related Party Transactions (Textual)
Vested shares	200,000

Shareholders' Equity (Details)

Shareholders' Equity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	3 Months Ended
	Jun. 30, 2020	Mar. 31, 2020
Outstanding beginning balance	3,200,000
Granted	1,442,895	4,000,000
Vested	(10,000)	(600,000)
Forfeited	(2,000,000)	(200,000)
Outstanding ending balance	2,632,895	3,200,000
Weighted average grant date fair value, beginning balance	0.62
Weighted average grant date fair value, Granted	$ 0.29	$ 0.63
Weighted average grant date fair value, vested	0.28	0.65
Weighted average grant date fair value, Forfeited	$ 0.60	$ 0.65
Weighted average grant date fair value, ending balance	0.46	0.62

Shareholders' Equity (Details T

Shareholders' Equity (Details Textual) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Mar. 31, 2020	Feb. 29, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Fair value of RSU’s vested			$ 2,750	$ 0	$ 392,810	$ 0
Unrecognized stock based compensation costs			987,249		987,249
Stock-based compensation expense			$ 58,842	$ 0	608,431	$ 0
Executive [Member]
Issuance of common stock shares		400,000
Board [Member]
Issuance of common stock shares		200,000
Directors [Member]
Stock-based compensation consisted of equity awards granted and vested					101,680
Employees [Member]
Stock-based compensation consisted of equity awards granted and vested					(59,091)
Issuance of common stock shares	1,175,549
Consultants [Member]
Stock-based compensation consisted of equity awards granted and vested					$ 16,253
Shareholders [Member]
Issuance of common stock shares					15,050,000
Shares of common stock cancelled					15,050,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Income Taxes (Textual)
Annual effective tax rates	(0.12%)
Federal statutory tax rate	21.00%
Income tax liability	$ 5,117
Net operating loss carry forward	$ 951,113	$ 583,001
Valuation reserve, percentage	100.00%

Commitments & Contingencies (De

Commitments & Contingencies (Details)	3 Months Ended	6 Months Ended
	Jun. 30, 2020USD ($)	Jun. 30, 2020USD ($)
Commitments & Contingencies (Textual)
Other lease payments	$ 14,229	$ 35,887
Operating lease cost	156,708	308,082
Present value of the liabilities decreased by acquisition of CMI	115,463	221,232
CMI Transaction [Member]
Commitments & Contingencies (Textual)
Right of use asset, net	$ 1,411,461	$ 1,411,461

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Aug. 04, 2020	Aug. 31, 2020
Shares of common stock, description	The Company received $250,000 in consideration for the sale of securities consisting of 250,000 shares of common stock and warrants exercisable into an additional 250,000 shares of common stock exercisable at a price of $0.25 per share with an expiration of twenty-four months from date of subscription.
Share subscriptions and issued	60,000
Gross proceeds	$ 15,000
Conversion price per share		$ 0.25
John Knapp [Member]
Convertible term note advance amount		$ 307,450
Convertible note maturity date		Jan. 31, 2021